Wilentz Shareholder Michael F. Schaff to Moderate NJICLE’s “The Latest in Cannabis and Regulated Substances Law” Program

Wednesday, October 25, 2023 1:00 PM to 5:00 PM

Wilentz Shareholder Michael F. Schaff, co-chair of the Corporate, Health, and Cannabis law practice groups and past co-chair of the NJSBA Cannabis Law Special Committee, will moderate “The Latest in Cannabis and Regulated Substances Law” program presented by NJICLE and the NJSBA Cannabis Law Special Committee. The panel, composed of experienced cannabis law attorneys, will provide a review of New Jersey’s expanding cannabis industry and related litigation, practical guidance regarding cannabis business operations, an overview of legalities and legislative developments regarding psychedelics, and a primer about general legislative and lobbying tactics and strategies.

The program agenda includes:

  • New Jersey Cannabis Regulations Two Years In: The Sticky and the Icky
  • Helping Your Client Manage Dispensary Finances
  • Municipal Litigation Update
  • Up Next: Psychedelics
  • Legislative Updates and Commentary

This program has been approved by the Board on Continuing Legal Education of the Supreme Court of New Jersey for 4.5 hours of total CLE credit (Full Credits Available: NJ General: 4.5).

For more information and to register, please visit the event page.

New Jersey Law Center, New Brunswick and Online

*Cannabis Law Disclaimer: Per federal law, under the Controlled Substances Act, marijuana is categorized as a Schedule I controlled substance.  Possession, use, distribution, and/or sale of cannabis is a Federal crime and is subject to related Federal policy, regardless of any state law that may authorize certain marijuana activity.  Compliance with state marijuana law does not equal compliance with federal law.  Legal advice provided by Wilentz, Goldman & Spitzer, P.A. is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Wilentz, Goldman & Spitzer, P.A. will not provide guidance or assistance in circumventing or violating Federal or state cannabis law or policy, and any advice provided by Wilentz, Goldman & Spitzer, P.A. should not be construed as such.

Michael F. Schaff Photo

Michael F. Schaff
Co-Chair, Corporate, Health and Cannabis Law Teams